Image (498b4ddd 7f47 477c Ba30 C3bdd8c7b8b7 02)
Nintedanib Capsules, 100 Mg And 150 Mg Capsule
Product Images NDC 76282-787
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Nintedanib Capsules, 100 Mg And 150 Mg (NDC 76282-787). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Exelan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image (498b4ddd 7f47 477c Ba30 C3bdd8c7b8b7 03)
Image (498b4ddd 7f47 477c Ba30 C3bdd8c7b8b7 04)
This text provides information on survival estimates using the Kapkan-Mhese methodology, with a hazard ratio of 0.70 and further details on death over 52 weeks.*
Image (498b4ddd 7f47 477c Ba30 C3bdd8c7b8b7 05)
Image (498b4ddd 7f47 477c Ba30 C3bdd8c7b8b7 06)
Image (498b4ddd 7f47 477c Ba30 C3bdd8c7b8b7 07)
Exelan-100mg-label (Exelan 100mg Label)
This text is not readable.*
Exelan-150mg-label (Exelan 150mg Label)
Not available.*
Figure-7 (Figure 7)
Figure-8 (Figure 8)
Figure-9 (Figure 9)
Structure (Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
